Monosomy of chromosome 8 could be considered as a primary preneoplastic event in breast cancer: A preliminary study
- PMID: 22740929
- PMCID: PMC3362558
- DOI: 10.3892/ol.2011.484
Monosomy of chromosome 8 could be considered as a primary preneoplastic event in breast cancer: A preliminary study
Abstract
This pilot study analyzed and compared the presence of chromosome 8 aneusomy in Mexican women with breast cancer and adjacent, intraductal, proliferative lesions. To determine the chromosome 8 copy number, we performed fluorescence in situ hybridization in nine patients (1800 cells) who underwent mastectomy. We selected two tissue samples from each patient, one corresponding to the invasive ductal carcinoma (IDC) and the other adjacent to the intraductal proliferative lesion (IPL). Breast tissue from 17 autopsy samples (1700 cells) was used as a control. The number of cells with monosomy, disomy and polysomy per subject and type of tissue were compared among the three groups of tissue with the RxC statistical software package using 50,000 total replicates. Chromosome 8 aneusomy was found in 66 and 67% of cells from the IDC and IPL samples, respectively. Monosomy was detected significantly more frequently in IPL compared with IDC samples (49.11 vs. 27.11%; p=0.0000), whereas polysomy was significantly more frequent in IDC compared with IPL samples (40.11 vs. 16.99%; p=0.00000). Control cells showed 92.3% disomy. These findings suggest that polysomy of chromosome 8 is more frequently observed in IDC and that monosomy is more frequent in tissue of IPL. Therefore, monosomy may be considered as a primary preneoplastic event. Future studies should be performed to increase the amount of breast tissue with ductal proliferative changes and with cancer, in order to support the results of this pilot study.
Figures

Similar articles
-
Clinicopathologic analysis of breast carcinoma with chromosomal aneusomy detected by fluorescence in situ hybridization.Cancer. 2001 Apr 25;93(2):165-70. doi: 10.1002/cncr.9024. Cancer. 2001. PMID: 11309784
-
[Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):584-8. Zhonghua Bing Li Xue Za Zhi. 2006. PMID: 17134563 Chinese.
-
Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization.Pathol Res Pract. 2000;196(4):227-33. doi: 10.1016/S0344-0338(00)80071-0. Pathol Res Pract. 2000. PMID: 10782466
-
Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.Lab Invest. 1999 Apr;79(4):387-93. Lab Invest. 1999. PMID: 10211991
-
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.Breast Cancer Res. 2005;7(2):R267-73. doi: 10.1186/bcr996. Epub 2005 Jan 26. Breast Cancer Res. 2005. PMID: 15743507 Free PMC article.
References
-
- Cardenas Sanchez J, Sandoval Guerrero F. Tercera Revisión del Consenso Nacional Sobre el Diagnóstico y Tratamiento del Cáncer Mamario. Ginecol Obstet Mex. 2010;78:199–212. - PubMed
-
- Visscher DW, Wallis TL, Crissman JD. Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics. Cancer. 1996;77:315–320. - PubMed
-
- Rojas-Atencio A, González L, Urdaneta K, et al. Cytogenetic findings in ductal carcinoma of the breast. Invest Clin. 1999;40:179–189. - PubMed
-
- Bieche I, Lidereau R. Genetic alterations in breast cancer. Genes Chromosomes Cancer. 1995;14:227–251. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases